-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation